Q15910 (EZH2_HUMAN) Homo sapiens (Human)

Histone-lysine N-methyltransferase EZH2 UniProtKBInterProSTRINGInteractive Modelling

746 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5); 9 identical sequences: Pongo abelii: A0A2J8S6W0; Pan troglodytes: K7C3W4, A0A803KHR1; Mandrillus leucophaeus: A0A2K6A6R9; Macaca nemestrina: A0A2K6DRW9; Macaca mulatta: H9Z6A2; Nomascus leucogenys: A0A2I3GCA7; Chlorocebus sabaeus: A0A0D9R3X6; Colobus angolensis palliatus: A0A2K5ILW0

Available Structures

22 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Structure of Human Polycomb Repressive Complex 2 (PRC2) with oncogenic histone H3K27M peptide Heteromer
O75530; P68431; Q15022; Q92833;
ZN;SAH;10-740
Assess
PRC2-AEBP2-JARID2 bound to H2AK119ub1 nucleosome Heteromer
O75530; P02281; P06897; P0CG48; P62799; P84233; Q09028; Q15022; Q6ZN18; Q92833;
MG;SAH;ZN;17-746
Assess
Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Extended Active State Heteromer
O75530; Q09028; Q15022; Q6ZN18; Q92833;
14-735
Assess
Structure of Human Polycomb Repressive Complex 2 (PRC2) with inhibitor Heteromer
O75530; Q15022; Q92833;
ZN;74D;10-728
Assess
Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Compact Active State Heteromer
O75530; Q09028; Q15022; Q6ZN18; Q92833;
17-735
Assess
Human Polycomb Repressive Complex 2 in complex with GSK126 inhibitor Heteromer
O75530; Q15022;
ZN;A9G;31-746
Assess
Histone H3 recognition by nucleosome-bound PRC2 subunit EZH2. Heteromer
P02281; P06897; P62799; P84233; Q15022;
ZN;SAH;113-740
Assess
Crystal Structure of an EZH2-EED Complex in an Oligomeric State Heteromer
O75530;
12-249
Assess
EED in complex with an allosteric PRC2 inhibitor EED666 Heteromer
O75530;
GOL;LQB;40-68
Assess
EED in complex with PRC2 allosteric inhibitor EED162 Heteromer
O75530;
LQF;40-68
Assess
Crystal structure of EED in complex with EZH2 peptide and compound 11# Heteromer
O75530;
EJU;40-68
Assess
EED in complex with PRC2 allosteric inhibitor EED709 Heteromer
O75530;
LQD;40-68
Assess
EED in complex with an allosteric PRC2 inhibitor Heteromer
O75530;
73K;40-68
Assess
EED in complex with PRC2 allosteric inhibitor compound 8 Heteromer
O75530;
LQG;40-68
Assess
EED in complex with PRC2 allosteric inhibitor compound 11 Heteromer
O75530;
LQH;40-68
Assess
Crystal structure of EED [G255D] in complex with EZH2 peptide and EED226 compound Heteromer
O75530;
GOL;73K;41-68
Assess
EED in complex with PRC2 allosteric inhibitor EED210 Heteromer
O75530;
LQE;40-66
Assess
Crystal structure of EED in complex with H3K27Me3 peptide and 3-(benzo[d][1,3]dioxol-4-ylmethyl)pip… Heteromer
O75530;
7W7;43-68
Assess
Crystal structure of EED in complex with H3K27Me3 peptide and 6-(benzo[d][1,3]dioxol-4-ylmethyl)-5,… Heteromer
O75530;
GOL;YT3;7WD;43-68
Assess
Crystal Structure of Ubl123 with an EZH2 peptide Heteromer
Q93009;
490-495
Assess
Crystal structure of the EZH2 SET domainmonomerSO4;ZN;521-731
Assess
Human Enhancer of Zeste (Drosophila) Homolog 2(EZH2)monomerZN;UNX;520-729
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomerZN;SAH;0.665hyn.1.A10-740
100.00
Assess

6 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomerZN;SAH;0.665hyn.1.A10-745
99.87
Assess
Isoform 3monomerZN;SAH;0.645hyn.1.A10-701
100.00
Assess
Isoform 3monomerZN;0.605ij7.2.A9-694
90.89
Assess
Isoform 3monomer0.536u4y.1.B12-210
92.93
Assess
Isoform 4monomerZN;SAH;0.665hyn.1.A10-731
100.00
Assess
Isoform 5monomerZN;SAH;0.665hyn.1.A10-689
99.86
Assess

Alignments